Technology Overview
Our innovative, single cell-based monoclonal antibody (SMAB) platform, can efficiently develop monoclonal antibodies from a variety of host animals, especially rabbits.
Compared with other commercial monoclonal antibody development platforms in the market, SMAB offers significant advantages:
SMab: Single cell-based, Speedy platform delivers Superior mAb for customers.
Advantages of SMabTM platform
  • Universal
  • Rabbit
  • Speedy
  • 50% shorter time
    High throughput
    High ratio of positive clones
  • Economical
  • IgG gene sequences
    Robust expression level
    No IP binding
  • Efficient
  • Guaranteed monoclonality
    Maintain antibody diversity
    Ready for functional assays